Logo image of SPRB

SPRUCE BIOSCIENCES INC (SPRB) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:SPRB - US85209E2081 - Common Stock

79.99 USD
+6.29 (+8.53%)
Last: 1/9/2026, 8:27:47 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to SPRB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 213.69. This target is 167.15% above the current price.
SPRB was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SPRB.
In the previous month the buy percentage consensus was at a similar level.
SPRB was analyzed by 10 analysts. More opinions would make the average more meaningful.
SPRB Historical Analyst RatingsSPRB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -62 -56 -50 -44 -38 -32 -26 -20 -14 -8 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 79.99161.60213.69213.69271.95 - 102.03% 167.15% 167.15% 239.98%
SPRB Current Analyst RatingSPRB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-12-23 Oppenheimer Initiate Outperform
2025-12-03 Leerink Partners Upgrade Market Perform -> Outperform
2025-11-11 Citizens Maintains Market Outperform -> Market Outperform
2025-10-28 JMP Securities Upgrade Market Perform -> Market Outperform
2025-10-21 Leerink Partners Maintains Market Perform -> Market Perform
2025-04-16 RBC Capital Maintains Sector Perform -> Sector Perform
2024-12-16 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-12-12 Guggenheim Reiterate Neutral -> Neutral
2024-12-11 JMP Securities Downgrade Market Outperform -> Market Perform
2024-12-11 Oppenheimer Downgrade Outperform -> Perform
2024-12-11 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-11-12 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-08-19 HC Wainwright & Co. Reiterate Neutral
2024-08-13 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-06-13 Oppenheimer Maintains Outperform -> Outperform
2024-06-05 HC Wainwright & Co. Reiterate Neutral
2024-05-14 HC Wainwright & Co. Reiterate Neutral
2024-03-14 Leerink Partners Downgrade Outperform -> Market Perform
2024-03-14 Ladenburg Thalmann Downgrade Buy -> Neutral
2024-03-14 Guggenheim Downgrade Buy -> Neutral
2024-03-14 JMP Securities Maintains Market Outperform -> Market Outperform
2024-03-14 RBC Capital Downgrade Outperform -> Sector Perform
2024-03-14 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-03-05 RBC Capital Reiterate Outperform -> Outperform
2024-02-26 RBC Capital Maintains Outperform -> Outperform
2024-02-21 Guggenheim Initiate Buy
2023-11-20 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-13 RBC Capital Reiterate Outperform -> Outperform
2023-09-13 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-08 SVB Leerink Upgrade Market Perform -> Outperform

SPRUCE BIOSCIENCES INC / SPRB FAQ

What do analysts expect the price target to be for SPRUCE BIOSCIENCES INC (SPRB)?

10 analysts have analysed SPRB and the average price target is 213.69 USD. This implies a price increase of 167.15% is expected in the next year compared to the current price of 79.99.


How do analysts rate SPRUCE BIOSCIENCES INC (SPRB)?

The consensus rating for SPRUCE BIOSCIENCES INC (SPRB) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.